CEL-SCI Corp(CVM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CVM CEL-SCI Corp

交易中 09-09 14:33:10 EDT

1.57

-0.08

-4.85%

最高1.67	最低1.57	成交量7.13万
今开1.66	昨收1.65	日振幅6.07%
总市值2,761万	流通市值2,646万	总股本1,759万
成交额11.61万	换手率0.42%	流通股本1,685万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CVM","market":"US","secType":"STK","nameCN":"CEL-SCI Corp","latestPrice":1.57,"timestamp":1788978486296,"preClose":1.65,"halted":0,"volume":71269,"delay":0,"changeRate":-0.048484848484848395,"floatShares":16851458,"shares":17588987,"eps":-2.568808,"marketStatus":"交易中","change":-0.08,"latestTime":"09-09 14:33:10 EDT","open":1.6627,"high":1.67,"low":1.5699,"amount":116149.6763647,"amplitude":0.060667,"askPrice":1.58,"askSize":180,"bidPrice":1.57,"bidSize":478,"shortable":3,"etf":0,"ttmEps":-2.568808,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1788984000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":433828800000,"exchange":"AMEX","adjPreClose":1.65,"preHourTrading":{"tag":"盘前","latestPrice":1.6348,"preClose":1.65,"latestTime":"09:10 EDT","volume":21,"amount":34.7304993,"timestamp":1788959413515,"change":-0.0152,"changeRate":-0.009212,"amplitude":0.081455},"postHourTrading":{"tag":"盘后","latestPrice":1.7056,"preClose":1.65,"latestTime":"19:47 EDT","volume":8256,"amount":14091.9502,"timestamp":1788911252914,"change":0.0556,"changeRate":0.033697,"amplitude":0.036364},"volumeRatio":0.671319,"impliedVol":1.3611,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/CVM/wiki","defaultTab":"wiki","newsList":[{"id":"2652421906","title":"哥伦比亚国家石油公司就收购要约上诉获巴西CVM支持，收购进程重启","url":"https://stock-news.laohu8.com/highlight/detail?id=2652421906","media":"环球市场播报","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652421906?lang=zh_cn&edition=full","pubTime":"2026-07-17 03:07","pubTimestamp":1784228820,"startTime":"0","endTime":"0","summary":"哥伦比亚国家石油公司Ecopetrol S.A．宣布，巴西证券交易委员会已就其控股子公司Ecopetrol Investimentos do Brasil针对公开收购要约提出的行政上诉作出有利裁决。　　CVM于7月14日召开董事会全体会议，裁定支持Ecopetrol Investimentos的上诉请求。根据官方公函，此前对收购要约施加的暂停措施已失效，CVM给予Ecopetrol Investimentos至7月22日的期限，用于修订并重新发布要约文件，其中包括确定新的拍卖日期。　　此次上诉的起因是CVM技术部门在7月初对收购要约的若干条款提出质疑，导致要约被暂停。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-17/doc-inihzvzn7506887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","CVM","BK4201","EC","MRGR","MNA","159100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126477861","title":"SCI与沙特Amarox于Bio 2026签署战略协议，推进美沙癌症治疗合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1126477861","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126477861?lang=zh_cn&edition=full","pubTime":"2026-06-24 20:00","pubTimestamp":1782302450,"startTime":"0","endTime":"0","summary":"在Bio 2026大会上，CEL-SCI公司与沙特Amarox公司成功举行了战略合作协议签署仪式。此举标志着双方在癌症治疗领域的合作迈出了关键一步，旨在共同推进美国与沙特阿拉伯在该领域的深入协作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184245622","title":"CEL-SCI公司通过美国双重注册研究与沙特市场准入策略推进头颈癌免疫疗法Multikine®","url":"https://stock-news.laohu8.com/highlight/detail?id=1184245622","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184245622?lang=zh_cn&edition=full","pubTime":"2026-06-16 20:05","pubTimestamp":1781611551,"startTime":"0","endTime":"0","summary":"CEL-SCI公司正通过一项双轨战略，推进其头颈癌免疫疗法Multikine®的研发与商业化进程。该战略一方面聚焦于在美国开展一项关键性的注册研究，旨在为产品上市铺平道路；另一方面，公司积极布局沙特阿拉伯市场，寻求新的商业机会。这一举措标志着该公司在拓展其核心肿瘤免疫治疗产品全球影响力的道路上迈出了重要步伐。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CVM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195290318","title":"CEL-SCI与沙特Amarox将在Bio 2026举行签约仪式，就Multikine®在沙特的商业化与分销达成战略协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1195290318","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195290318?lang=zh_cn&edition=full","pubTime":"2026-06-12 20:00","pubTimestamp":1781265625,"startTime":"0","endTime":"0","summary":"为了推进其癌症免疫疗法Multikine®在沙特阿拉伯王国的商业化与分销进程，CEL-SCI公司（CEL-SCI Corp）与沙特本土企业Amarox已达成一项战略合作协议。双方计划于即将到来的Bio 2026国际生物技术大会期间，正式举行签约仪式。\n此举标志着Multikine®进入中东关键市场的重要一步。根据协议，双方将整合资源与专长，共同致力于满足沙特地区未被满足的医疗需求，并加速该创新疗法的市场渗透。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640631861","title":"亿华通：公司柔性CVM系统主要应用于氢燃料电池及配套监测类产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2640631861","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640631861?lang=zh_cn&edition=full","pubTime":"2026-06-04 22:00","pubTimestamp":1780581600,"startTime":"0","endTime":"0","summary":"证券日报网讯6月4日，亿华通在互动平台回答投资者提问时表示，公司柔性CVM系统主要应用于氢燃料电池及配套监测类产品，目前主要面向交通、固定式发电及热电联供等地面应用场景布局，未应用于太空光伏领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606043760731312.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606043760731312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["HYDR","02402","BK1171","BK4139","LIT","CVM","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197225852","title":"CEL-SCI与Amarox达成战略协议，将在沙特阿拉伯推进Multikine的注册、商业化与分销","url":"https://stock-news.laohu8.com/highlight/detail?id=1197225852","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197225852?lang=zh_cn&edition=full","pubTime":"2026-05-11 20:03","pubTimestamp":1778501030,"startTime":"0","endTime":"0","summary":"生物技术公司CEL-SCI Corp宣布，已与Amarox公司签署一项战略合作协议。该协议的核心内容是，双方将携手在沙特阿拉伯市场推进其免疫治疗药物Multikine的注册审批、商业化运营以及分销网络建设。此举标志着CEL-SCI在中东地区市场拓展迈出了关键一步，旨在加速其创新疗法进入该重要区域。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CVM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179989716","title":"CEL-SCI公司宣布：Multikine获SFDA批准后，Amarox将成为其在沙特阿拉伯的独家商业分销商","url":"https://stock-news.laohu8.com/highlight/detail?id=1179989716","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179989716?lang=zh_cn&edition=full","pubTime":"2026-05-11 20:03","pubTimestamp":1778501021,"startTime":"0","endTime":"0","summary":"CEL-SCI公司宣布，其抗癌药物Multikine在获得沙特阿拉伯食品药品监督管理局（SFDA）批准后，Amarox公司将成为该药物在沙特阿拉伯市场的独家商业分销商。这一合作标志着CEL-SCI在中东地区商业布局的重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CVM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629137022","title":"巴西利亚银行股东批准18亿美元增资计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2629137022","media":"环球市场播报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2629137022?lang=zh_cn&edition=full","pubTime":"2026-04-23 03:25","pubTimestamp":1776885900,"startTime":"0","endTime":"0","summary":"2026年4月22日，巴西利亚银行宣布，其股东在特别股东大会上正式批准了一项高达18亿美元的增资计划。此次资本扩充旨在为银行的持续扩张和战略投资提供资金支持。　　根据巴西利亚银行向证券交易委员会提交的公告，该增资方案已获得多数股东投票通过。　　增资完成后，巴西利亚银行的资本充足率将进一步提升，有助于增强其风险抵御能力和市场竞争力。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-23/doc-inhvmmmu4023475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","CVM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619727431","title":"华泰｜美国宠物功能粮百亿市场透视：研发定格局","url":"https://stock-news.laohu8.com/highlight/detail?id=2619727431","media":"华泰睿思","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2619727431?lang=zh_cn&edition=full","pubTime":"2026-03-15 09:00","pubTimestamp":1773536400,"startTime":"0","endTime":"0","summary":"近期乖宝旗下弗列加特品牌推出减重粮、英短及布偶专用粮三款新品，中宠顽皮小金盾推出“功能烘焙系列”，功能粮及处方粮成为头部宠企布局重点。基于此，我们对美国宠物食品功能粮行业进行深度剖析。我们首次对功能粮进行概念界定、市场规模估算，并深挖美国宠物食品审核流程，解析头部宠企研发壁垒。我们认为功能粮这种长研发周期、高壁垒的产品有望打破当前行业内卷格局，研发实力突出的头部宠企有望率先受益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA5NDI5MDQwMg==&mid=2649845596&idx=1&sn=fd07312c93b4b52942e23b684c7a263e&chksm=89a3885a4184bc078cf1fc64b34d6981c3a9ca1e9646c9e6b72a24f8587ff41092326a321f17&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK4139","RCT","BK4159","CVM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518016652","title":"Cel-Sci Corporation盘中异动 股价大跌6.63%报0.324美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518016652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518016652?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:44","pubTimestamp":1741632274,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时44分，Cel-Sci Corporation股票出现异动，股价急速下挫6.63%。截至发稿，该股报0.324美元/股，成交量39.8178万股，换手率0.52%，振幅5.31%。Cel-Sci Corporation股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6096.12%、3850.90%、1008.95%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311024434abf36f5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311024434abf36f5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517162057","title":"Cel-Sci Corporation盘中异动 早盘急速拉升5.08%报0.348美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517162057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517162057?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:08","pubTimestamp":1741277330,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时08分，Cel-Sci Corporation股票出现波动，股价快速拉升5.08%。截至发稿，该股报0.348美元/股，成交量28.5876万股，换手率0.37%，振幅8.28%。Cel-Sci Corporation股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.涨幅较大，Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2899.98%、1895.69%、125.70%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Aeon Biopharma, Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为68.33%、67.37%、57.40%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000850abeb8f21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000850abeb8f21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514838576","title":"Cel-Sci Corporation盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514838576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514838576?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:38","pubTimestamp":1740667117,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时38分，Cel-Sci Corporation股票出现波动，股价大幅下跌5.08%。截至发稿，该股报0.321美元/股，成交量18.2106万股，换手率0.24%，振幅4.79%。Cel-Sci Corporation股票所在的生物技术行业中，整体涨幅为0.95%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Alector, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为444.34%、93.13%、72.97%，振幅较大的相关个股有Channel Therapeutics Corporation、Quoin Pharmaceuticals Ltd、Aurinia Pharmaceuticals Inc，振幅分别为16.59%、15.14%、14.91%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223837abdf7095&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223837abdf7095&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514286615","title":"Cel-Sci Corporation盘中异动 股价大跌5.13%报0.340美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514286615","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514286615?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:07","pubTimestamp":1740593243,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时07分，Cel-Sci Corporation股票出现波动，股价急速跳水5.13%。截至发稿，该股报0.340美元/股，成交量53.0902万股，换手率0.69%，振幅7.50%。Cel-Sci Corporation股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Renovaro Inc.涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6399.58%、261.63%、239.71%，振幅较大的相关个股有Enveric Biosciences, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Pds Biotechnology Corporation，振幅分别为194.07%、49.18%、44.44%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227020724abde1c96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227020724abde1c96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514021090","title":"Cel-Sci Corporation盘中异动 大幅跳水5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514021090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514021090?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:35","pubTimestamp":1740494157,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时35分，Cel-Sci Corporation股票出现波动，股价急速跳水5.44%。截至发稿，该股报0.372美元/股，成交量14.2575万股，换手率0.18%，振幅5.36%。Cel-Sci Corporation股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Moleculin Biotech, Inc.、Silexion Therapeutics Corp、Adial Pharmaceuticals, Inc涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为775.15%、490.79%、259.65%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Gt Biopharma, Inc.、Moleculin Biotech, Inc.，振幅分别为20.51%、18.23%、15.89%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522355798924dbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522355798924dbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513940241","title":"武汉鼎元同立申请基于CVM分析的Modelica系统仿真模型参数辨识方法专利，提升电力系统的仿真置信度","url":"https://stock-news.laohu8.com/highlight/detail?id=2513940241","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513940241?lang=zh_cn&edition=full","pubTime":"2025-02-22 08:12","pubTimestamp":1740183120,"startTime":"0","endTime":"0","summary":"金融界2025年2月22日消息，国家知识产权局信息显示，武汉鼎元同立科技有限公司申请一项名为“基于CVM分析的Modelica系统仿真模型参数辨识方法”的专利，公开号 CN 119494194 A，申请日期为2024年10月。专利摘要显示，本发明提供基于CVM分析的Modelica系统仿真模型参数辨识方法，涉及系统建模仿真技术领域。通过天眼查大数据分析，武汉鼎元同立科技有限公司参与招投标项目1次，专利信息21条，此外企业还拥有行政许可2个。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/22081248322548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CVM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513729611","title":"Cel-Sci Corporation盘中异动 急速下跌5.44%报0.400美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513729611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513729611?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:38","pubTimestamp":1740148716,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时38分，Cel-Sci Corporation股票出现异动，股价大幅下挫5.44%。截至发稿，该股报0.400美元/股，成交量26.6797万股，换手率0.35%，振幅3.05%。Cel-Sci Corporation股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Nkgen Biotech, Inc.、Omega Therapeutics, Inc.、Estrella Immunopharma, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、蓝鸟生物较为活跃，换手率分别为73.85%、68.21%、21.47%，振幅较大的相关个股有Osr Holdings Inc C/Wts 09/02/2028 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Omega Therapeutics, Inc.，振幅分别为46.92%、33.83%、24.74%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223836abd7b130&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223836abd7b130&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512484716","title":"Cel-Sci Corporation盘中异动 股价大涨5.36%报0.470美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512484716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512484716?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:36","pubTimestamp":1739983005,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时36分，Cel-Sci Corporation股票出现波动，股价快速拉升5.36%。截至发稿，该股报0.470美元/股，成交量25.4601万股，换手率0.33%，振幅4.62%。Cel-Sci Corporation股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为591.56%、245.04%、199.65%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Aditxt, Inc.，振幅分别为207.68%、159.49%、48.18%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003645abd51731&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003645abd51731&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512031165","title":"Cel-Sci Corporation盘中异动 大幅下挫5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512031165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512031165?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:35","pubTimestamp":1739889323,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时35分，Cel-Sci Corporation股票出现异动，股价大幅下挫5.59%。截至发稿，该股报0.394美元/股，成交量61.213万股，换手率0.79%，振幅9.98%。Cel-Sci Corporation股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为284.26%、100.36%、75.51%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.、Glycomimetics, Inc.，振幅分别为34.04%、22.30%、18.69%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223523a24aadb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223523a24aadb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510385433","title":"Cel-Sci Corporation盘中异动 股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510385433","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510385433?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:42","pubTimestamp":1739284934,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时42分，Cel-Sci Corporation股票出现异动，股价大幅下挫5.31%。截至发稿，该股报0.341美元/股，成交量11.7679万股，换手率0.16%，振幅3.89%。Cel-Sci Corporation股票所在的生物技术行业中，整体跌幅为1.34%。其相关个股中，Dominari Holdings Inc.、Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2280.07%、597.88%、237.09%，振幅较大的相关个股有Ocean Biomedical, Inc.、In8Bio, Inc.、Dominari Holdings Inc.，振幅分别为33.04%、31.80%、31.17%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224214abcb08a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224214abcb08a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCEA","CVM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510362899","title":"Cel-Sci Corporation盘中异动 下午盘股价大跌7.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510362899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510362899?lang=zh_cn&edition=full","pubTime":"2025-02-11 02:44","pubTimestamp":1739213063,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日02时44分，Cel-Sci Corporation股票出现异动，股价急速下跌7.60%。截至发稿，该股报0.350美元/股，成交量26.0877万股，换手率0.35%，振幅4.99%。Cel-Sci Corporation股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Biodexa Pharmaceuticals Plc、Dominari Holdings Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为3075.99%、1646.06%、1353.56%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Abpro Holdings Inc C/Wts 12/11/2029 、Biodexa Pharmaceuticals Plc，振幅分别为99.86%、87.80%、87.71%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211024423abc9db79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211024423abc9db79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cel-sci.com","stockEarnings":[{"period":"1week","weight":0.0248},{"period":"1month","weight":-0.0407},{"period":"3month","weight":0.3983},{"period":"6month","weight":-0.5313},{"period":"1year","weight":-0.8406},{"period":"ytd","weight":-0.6863}],"compareEarnings":[{"period":"1week","weight":0.0055},{"period":"1month","weight":-0.0094},{"period":"3month","weight":0.0559},{"period":"6month","weight":0.15},{"period":"1year","weight":0.1805},{"period":"ytd","weight":0.1232}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CEL-SCI Corporation于1983年3月22日成立注册于科罗拉多州，为生物医学科学的研究和开发提供资金，并最终从事营销和销售产品。CEL-SCI Corporation致力于研究和开发旨在通过利用免疫系统——人体的自然防御系统——来改善癌症和其他疾病的治疗。该公司目前致力于开发Multikine，一种针对某些头颈部癌症的研究性3期免疫疗法，以及L.E.A.P.S.（Ligand表位抗原呈报系统）技术，其中包括几个针对类风湿性关节炎潜在治疗的候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.651163,"avgChangeRate":0.168144},{"month":2,"riseRate":0.302326,"avgChangeRate":0.008808},{"month":3,"riseRate":0.348837,"avgChangeRate":-0.03649},{"month":4,"riseRate":0.55814,"avgChangeRate":0.120159},{"month":5,"riseRate":0.255814,"avgChangeRate":-0.034036},{"month":6,"riseRate":0.395349,"avgChangeRate":-0.001561},{"month":7,"riseRate":0.209302,"avgChangeRate":-0.000167},{"month":8,"riseRate":0.372093,"avgChangeRate":0.048289},{"month":9,"riseRate":0.372093,"avgChangeRate":0.045676},{"month":10,"riseRate":0.309524,"avgChangeRate":-0.077364},{"month":11,"riseRate":0.404762,"avgChangeRate":0.012679},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.013127}],"exchange":"AMEX","name":"CEL-SCI Corp","nameEN":"CEL-SCI Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CEL-SCI Corp(CVM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CEL-SCI Corp(CVM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CEL-SCI Corp,CVM,CEL-SCI Corp股票,CEL-SCI Corp股票老虎,CEL-SCI Corp股票老虎国际,CEL-SCI Corp行情,CEL-SCI Corp股票行情,CEL-SCI Corp股价,CEL-SCI Corp股市,CEL-SCI Corp股票价格,CEL-SCI Corp股票交易,CEL-SCI Corp股票购买,CEL-SCI Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CEL-SCI Corp(CVM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CEL-SCI Corp(CVM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}